Edith T Zemanick

Summary

Affiliation: University of Colorado
Country: USA

Publications

  1. pmc Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens
    Edith T Zemanick
    Department of Pediatrics, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado, United States of America
    PLoS ONE 5:e15101. 2010
  2. doi request reprint The airway microbiome in cystic fibrosis and implications for treatment
    Edith T Zemanick
    Department of Pediatrics, University of Colorado Denver, Aurora, Colorado, USA
    Curr Opin Pediatr 23:319-24. 2011
  3. pmc Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy
    Edith T Zemanick
    Department of Pediatrics, University of Colorado Denver, 13123 E 16th Avenue, Aurora, CO 80045, USA
    J Cyst Fibros 9:1-16. 2010
  4. pmc Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures
    Edith T Zemanick
    Department of Pediatrics, University of Colorado Denver, Aurora, Colorado 80045, USA
    Pediatr Pulmonol 45:569-77. 2010
  5. pmc Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations
    Edith T Zemanick
    Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America
    PLoS ONE 8:e62917. 2013
  6. pmc Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis
    Scott D Sagel
    Children s Hospital Colorado, 13123 E 16th Avenue, Aurora, CO 80045, USA
    Am J Respir Crit Care Med 186:857-65. 2012

Detail Information

Publications6

  1. pmc Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens
    Edith T Zemanick
    Department of Pediatrics, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado, United States of America
    PLoS ONE 5:e15101. 2010
    ..influenzae from CF airway samples. By reliably quantifying fastidious airway bacteria, qPCR may improve our understanding of polymicrobial CF lung infections, progression of lung disease and ultimately improve antimicrobial treatments...
  2. doi request reprint The airway microbiome in cystic fibrosis and implications for treatment
    Edith T Zemanick
    Department of Pediatrics, University of Colorado Denver, Aurora, Colorado, USA
    Curr Opin Pediatr 23:319-24. 2011
    ..Recent studies using culture-independent molecular techniques and anaerobic cultures have broadened our view of CF airway bacterial communities...
  3. pmc Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy
    Edith T Zemanick
    Department of Pediatrics, University of Colorado Denver, 13123 E 16th Avenue, Aurora, CO 80045, USA
    J Cyst Fibros 9:1-16. 2010
    ..This review highlights emerging treatments, obstacles to optimizing outcomes, and key future directions for research...
  4. pmc Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures
    Edith T Zemanick
    Department of Pediatrics, University of Colorado Denver, Aurora, Colorado 80045, USA
    Pediatr Pulmonol 45:569-77. 2010
    ..Exacerbations are often associated with characteristic airway bacteria [CF related bacteria (CFRB)]. However, some patients do not have CFRB detected by culture during exacerbations...
  5. pmc Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations
    Edith T Zemanick
    Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America
    PLoS ONE 8:e62917. 2013
    ..Molecular microbiologic approaches detect complex microbiota from CF airway samples taken during PEx. The relationship between airway microbiota, inflammation, and lung function during CF PEx is not well understood...
  6. pmc Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis
    Scott D Sagel
    Children s Hospital Colorado, 13123 E 16th Avenue, Aurora, CO 80045, USA
    Am J Respir Crit Care Med 186:857-65. 2012
    ..Progressive lung function decline is a defining feature of cystic fibrosis (CF). Because airway inflammation plays a central role in CF lung disease, inflammatory biomarkers that can be used to monitor disease activity would be valuable...